16:03 EST Arrowhead reports FY23 EPS ($1.92), consensus ($1.55)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ARWR:
- Arrowhead files for clearance to begin study of ARO-DM1 for DM1 treatment
- ARWR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Arrowhead: Plozasiran achieved mean max reductions of up to 90% in APOC3
- GSK, Arrowhead announce deal with Janssen for rights to JNJ-3989